Glucagon-Like Peptide-1 Receptor Agonist (GLP-1RA) Therapy Adherence for Patients with Type 2 Diabetes in a Medicare Population

INTRODUCTION: Anti-diabetes medication regimen adherence is a clinical challenge in elderly patients with type 2 diabetes (T2D) and other comorbidities associated with aging. Glucagon-like peptide-1 receptor agonists (GLP-1RA) therapies such as exenatide once weekly (QW), exenatide twice daily (BID)...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Hiep, Dufour, Robert, Caldwell-Tarr, Amanda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5350190/
https://www.ncbi.nlm.nih.gov/pubmed/28078541
http://dx.doi.org/10.1007/s12325-016-0470-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5350190/
https://www.ncbi.nlm.nih.gov/pubmed/28078541
http://dx.doi.org/10.1007/s12325-016-0470-y

Ejemplares similares